DNA/RNA

Expression
Widely expressed, expression is very high in proliferative cells, embryonic cells, haematopoietic progenitor cells.
Localisation
Nucleus.
Function
Transcription factor required for cell proliferation, cell cycle progression, chromosomal stability and differentiation. B-MYB knockout mice die at E4.5-E6.5 due to early developmental arrest.
Homology
B-MYB is a member of MYB transcription factors family, which includes C-MYB and A-MYB, with high homology within TA and RD regions. DNA-binding domain is almost identical with that of A-MYB and C-MYB and conserved between mouse, human, chicken and drosophila.
Implicated in
Neuroblastoma
Prognosis
Overexpression is thought to be associated with a poor outcome of the disease. Oncogenesis Was reported to be necessary for survival and differentiation of neuroblastoma cells.
Hepatocellular carcinoma (HCC)
Oncogenesis B-MYB is reported to be a probable target of E2F1 transcription factor, which is dramatically overexpressed in HCC. There is a clear correlation between expression level of these two proteins. B-MYB overexpression in HCC causes the deregulation of apoptosis and cell cycle.
Various cancer
Disease Amplification of B-MYB was described in breast carcinomas, liver carcinomas, ovarian carcinomas and in cutaneous T lymphoma. B-MYB expression was shown also to be increased in prostate and testicular malignancies. Moreover, B-MYB expression is notably increased in metastatic compared to localised prostate tumours.
The presence of B-MYB polymorphisms rs2070235 and rs11556379 is associated with a significant reduction of cancer risk. Oncogenesis B-MYB overexpression may result in promotion of cancer cells survival and proliferation. Polimorphisms can induce changes in protein conformation and therefore may in part deactivate B-MYB functions.
